Association of adipokines and adhesion molecules with indicators of obesity in women undergoing mammography screening

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Isoppo De Souza, Caroline ^a   Rosa, Daniela Dornelles ^a,b,c   Ettrich, Betina ^a   Cibeira, Gabriela Hermann ^a   Giacomazzi, Juliana ^a,d   Tusset, Paloma ^a   Ashton Prolla, Patrícia ^a,d,e   Medeiros, Lidia Rosi ^a   Caleffi, Maira ^a,c,g   Neto, Eurico Camargo ^f   Moriguchi, Emilio Hideyuki ^a   Graudenz, Marcia Silveira ^a,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL MOINHOS DE VENTO   (Brazil)

^c Grupo Brasileiro de Estudos Do Câncer de Mama GBECAM   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e Instituto Nacional de Genética Médica Populacional INAGEMP   (Brazil)

^f Laboratório Nobel Sociedade Simples Ltda   (Brazil)

^g Núcleo Mama Porto Alegre NMPOA   (Brazil)

Author keywords

Adiponectin; Intercellular Adhesion Molecule 1; Obesity; Plasminogen Activator Inhibitor type 1; Vascular Cell Adhesion Molecule 1

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BREAST CANCER; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAMMOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; WAIST HIP RATIO;

EID: 84868241906     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-97     Document Type: Article

References (46)

1. NEPA-UNICAMP, Tabela brasileira de composição de alimentos / NEPA-UNICAMP- T113 Versão II Campinas: SP: NEPA-UNICAMP 2 2006 113
2. Adherence to a breast cancer screening program and its predictors in underserved women in southern Brazil. Caleffi M, Ribeiro RA, Bedin AJ Jr, Viegas-Butzke JM, Baldisserotto FD, Skonieski GP, Giacomazzi J, Camey SA, Ashton-Prolla P, Cancer Epidemiol Biomarkers Prev 2010 19 10 2673 2679 Epub 2010 Aug 17 10.1158/1055-9965.EPI-10-0338 20716620
3. IBGE, Ministério da Saúde. Pesquisa de Orçamentos Familiares 2008-2009: antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil Rio de Janeiro: IBGE 2010 20060727
4. Role of obesity and exercise in breast cancer survivors. Nagaiah G, Hazard HW, Abraham J, Oncology (Williston Park) 2010 24 4 342 346
5. The influence of obesity and different fat depots on adipose tissue gene expression and protein levels of cell adhesion molecules. Bosanská L, Michalský D, Lacinová Z, Dostálová I, Bártlová M, Haluzíková D, Matoulek M, Kasalický M, Haluzík M, Physiol Res 2010 59 1 79 88 19249917
6. Integrative physiology of human adipose tissue. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW, Int J Obes Relat Metab Disord 2003 27 8 875 888 10.1038/sj.ijo.0802326 12861227
7. Associations of insulin resistance and adiponectin with mortality in women with breast cancer. Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R, McTiernan A, J Clin Oncol 2011 29 1 32 39 10.1200/JCO.2009.26.4473 21115858
8. Early upregulation of endothelial adhesion molecules in obese hypertensive men. Ferri C, Desideri G, Valenti M, et al. Hypertension 1999 34 568 573 10.1161/01.HYP.34.4.568 10523328
9. Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: The possible role of metabolic control and oxidative stress. Ceriello A, Falleti E, Bortolotti N, et al. Metabolism 1996 45 498 501 10.1016/S0026-0495(96)90226-7 8609838
10. Adipokines and the paracrine control of their production in obesity and diabetes. Lau D, Yan H, Abdel-Hafez M, Kermouni A, Int J Obes Relat Metab Disord 2002 26 111 10.1038/sj.ijo.0801856
11. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K, Nagai R, Biochem Biophys Res Commun 2004 314 2 415 419 10.1016/j.bbrc.2003.12.104 14733921
12. Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Rohde LEP, Hennekens CH, Ridker PM, Arterioscler Thromb Vasc Biol 1999 19 1595 1599 10.1161/01.ATV.19.7. 1595 10397675
13. Adiponectin and breast cancer risk. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, Trichopoulos D, J Clin Endocrinol Metab 2004 89 3 1102 1107 10.1210/jc.2003-031804 15001594
14. Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Kruithof EK, Thromb Haemost 2008 100 6 969 975 19132219
15. Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, Laughlin GA, Saquib N, Rock CL, Pierce JP, J Clin Oncol 2011 29 1 54 60 10.1200/JCO.2010.29.3183 21115861
16. Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population. Miller MA, Cappuccio FP, Int J Obes (Lond) 2006 30 8 1176 1182 10.1038/sj.ijo.0803264
17. 2003 Soluble adhesion molecules in female patients with breast carcinoma. Tesarova, Cas Lek Cesk 2003 142 5 292 299 12920795
18. A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil.(Porto Alegre Breast Health Intervention Cohort). Caleffi M, Ribeiro RA, Duarte Filho DL, Ashton-Prolla P, Bedin AJ Jr, Skonieski GP, Zignani JM, Giacomazzi J, Franco LR, Graudenz M, Pohlmann P, Fernandes JG, Kivitz P, Weber B, BMC Publ Health 2009 9 83 Mar 13 10.1186/1471-2458-9-83
19. Brasil. Ministério da Saúde, SISVAN. Sistema de vigilância alimentar e nutricional. Orientações para coleta e análise dos dados antropométricos em serviços de saúde. Normas técnicas Brasília: o Ministério 2008
20. World Health Organization/Food and Agriculture Organization, Diet, nutrition and the prevention of chronic diseases Geneva: World Health Organization 2003 (Technical Report Series, 916)
21. Cancer disparities by race/ethnicity and socioeconomic status. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M, CA Cancer J Clin 2004 54 2 78 93 10.3322/canjclin.54.2.78 15061598
22. Dimensions of socioeconomic position related to body mass index and obesity among Danish women and men. Groth MV, Fagt S, Stockmarr A, Matthiessen J, Biltoft-Jensen A, Scand J Public Health 2009 37 4 418 426 10.1177/1403494809105284 19470691
23. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cesari M, Pahor M, Incalzi RA, Cardiovasc Ther 2010 28 5 72 e91 10.1111/j.1755-5922.2010. 00171.x 20626406
24. Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men. Byberg L, Siegbahn A, Berglund L, McKeigue P, Reneland R, Lithell H, Arterioscler Thromb Vasc Biol 1998 18 2 258 264 10.1161/01.ATV.18.2.258 9484991
25. Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men. Cigolini M, Targher G, Seidell JC, Schiavon R, Manara F, Zenti MG, Mattioli C, De Sandre G, Atherosclerosis 1994 106 2 139 147 10.1016/0021-9150(94)90119-8 8060375
26. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Bastelica D, Morange P, Berthet B, Borghi H, Lacroix O, Grino M, Juhan-Vague I, Alessi MC, Arterioscler Thromb Vasc Biol 2002 22 173 178 10.1161/hq0102.101552 11788479
27. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss. Mavri A, Alessi MC, Bastelica D, et al. Diabetologia 2001 44 2025 2031 10.1007/s001250100007 11719834
28. Adipocytokines and metabolic syndrome. Matsuzawa Y, Semin Vasc Med 2005 5 34 39 10.1055/s-2005-871744 15968578
29. Use of confirmatory factor analysis for the identification of new components of the metabolic syndrome: the role of plasminogen activator inhibitor-1 and Haemoglobin A1c. Boronat M, Saavedra P, Varillas VF, Nóvoa FJ, Nutr Metab Cardiovasc Dis 2009 19 4 271 276 10.1016/j.numecd.2008.07.007 18809301
30. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Sam S, Haffner S, Davidson MH, D'Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T, Diabetes Care 2009 32 5 932 937 10.2337/dc08-1856 19228869
31. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, Ouyang P, Folsom AR, J Thromb Haemost 2006 4 12 2629 2635 10.1111/j.1538-7836.2006.02237.x 17002663
32. Weight reduction decreases soluble cellular adhesion molecules in obese women. Ito H, Ohshima A, Inoue M, et al. Clin Exp Pharmacol Physiol 2002 29 399 404 10.1046/j.1440-1681.2002.03672.x 12010183
33. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y, Biochem Biophys Res Commun 1999 257 79 83 10.1006/bbrc.1999.0255 10092513
34. Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/actin-dependent mechanism. Bedi D, Clarke KJ, Dennis JC, Zhong Q, Brunson BL, Morrison EE, Judd RL, Biochem Biophys Res Commun 2006 345 1 332 339 10.1016/j.bbrc.2006.04.098 16682005
35. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE, Diabetologia 2003 46 4 459 469 12687327
36. Expression levels of vascular cell adhesion molecule-1 in young and nonobese women with polycystic ovary syndrome. Seow KM, Juan CC, Wang PH, Ho LT, Hwang JL, Gynecol Obstet Invest 2012 73 3 236 241 10.1159/000334175 22441212
37. Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Pontiroli AE, Pizzocri P, Koprivec D, Vedani P, Marchi M, Arcelloni C, Paroni R, Esposito K, Giugliano D, Eur J Endocrinol 2004 150 2 195 200 10.1530/eje.0.1500195 14763917
38. Weight reduction decreases soluble cellular adhesion molecules in obese women. Ito H, Ohshima A, Inoue M, Ohto N, Nakasuga K, Kaji Y, Maruyama T, Nishioka K, Clin Exp Pharmacol Physiol 2002 29 5-6 399 404 12010183
39. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Trayhurn P, Wood IS, Br J Nutr 2004 92 3 347 355 10.1079/BJN20041213 15469638
40. Hypoadiponectinemia is an independent risk factor for hypertension. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T, Hypertension 2004 43 6 1318 1323 10.1161/01.HYP.0000129281.03801.4b 15123570
41. Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Uslu S, Kebapci N, Kara M, Bal C, Exp Rev Med 2012 4 1 113 120
42. Adiponectin and cardiovascular disease: state of the art? Szmitko PE, Teoh H, Stewart DJ, Verma S, Am J Physiol Heart Circ Physiol 2007 292 4 1655 H1663 17142348
43. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y, Diabetes 2002 51 9 2734 2741 10.2337/diabetes.51.9.2734 12196466
44. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Shand BI, Scott RS, Elder PA, George PM, Diabetes Obes Metab 2003 5 5 349 353 10.1046/j.1463-1326.2003.00279.x 12940874
45. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY, Hou MF, Yuan SS, Cancer Lett 2006 237 1 109 114 10.1016/j.canlet.2005.05.047 16019138
46. Targeting the adiponectin:leptin ratio for postmenopausal breast cancer prevention. Cleary MP, Ray A, Rogozina OP, Dogan S, Grossmann ME, Front Biosci (Schol Ed) 2009 1 329 357